Equity Profile

CYRX

Cryoport, Inc.

Health CareLife Sciences Tools & Services$766.3M

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Cryoport, Inc. is a healthcare company that specializes in providing temperature-controlled supply chain solutions for the life sciences industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs.

$-0.18

Revenue

Revenue figures will indicate the company's sales performance and growth trajectory in a competitive market.

$48M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CYRX Q2-2026 Earnings Preview

Context

Company Snapshot

Cryoport, Inc. is a healthcare company that specializes in providing temperature-controlled supply chain solutions for the life sciences industry. With a market cap of $1 billion, it plays a crucial role in the logistics of biopharmaceutical products, which is increasingly important as the demand for advanced therapies grows.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+98.90%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, Cryoport reported an EPS of $-0.25, missing estimates and reflecting ongoing challenges in profitability. The stock dropped 1.35% the following day, indicating market disappointment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Cryoport to report a loss, but revenue is anticipated to show modest growth. The market is closely watching for any signs of improvement in operational efficiency.

Bull Case

If Cryoport can exceed revenue expectations and show a smaller loss than anticipated, it could signal a turnaround in performance, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet revenue targets or reports a larger loss, it could raise concerns about its long-term viability and lead to a significant stock decline.

Key Metrics to Watch

EPS

$-0.18

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs.

Revenue

$48M

Revenue figures will indicate the company's sales performance and growth trajectory in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS come in better than the expected $-0.18?

A smaller loss could indicate improved cost management and operational efficiency, which is critical for investor confidence.

What is the outlook for revenue growth compared to the $48M consensus?

Revenue growth is essential for demonstrating the company's ability to capture market share and sustain its operations.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Cryoport's potential for revenue growth due to recent investments in expanding its logistics capabilities.

Supporting Evidence

The options market is pricing a 25.97% move, indicating expectations of significant volatility.

Past earnings surprises show that the company has occasionally exceeded expectations despite a challenging environment.

Key Risk

If revenue comes in above $49M, it could challenge the current bearish sentiment and shift investor outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results are pivotal in determining whether Cryoport can stabilize its financials and regain investor trust.

Bull Confirmed If

Revenue exceeding $48M with EPS better than $-0.18 would confirm a positive outlook.

Bear Confirmed If

Revenue falling below $47M or a larger EPS loss than $-0.20 would confirm concerns about the company's performance.

Pre-Earnings Positioning

Options Market

Implied Move

±25.97%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±26.0% while CYRX has averaged ±3.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

69.4%

Calls (307K)P/C Ratio: 0.00Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cryoport beats expectations, history suggests a potential stock increase of around 1.99% on the first day, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await further clarity on future growth.

Miss

If the company misses estimates, history suggests a potential decline of about 2.78%, reinforcing negative sentiment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Details on cost management strategies and their impact on EPS.
3Insights into market demand for temperature-controlled logistics services.
4Management's commentary on competitive positioning in the life sciences sector.
5Future guidance on revenue expectations for the next quarter.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Cryoport, Inc. is a healthcare company that specializes in providing temperature-controlled supply chain solutions for the life sciences industry....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs.

$-0.18

Revenue

Revenue figures will indicate the company's sales performance and growth trajectory in a competitive market.

$48M

Wall Street expectations, options signals, track record, and call prep available with Pro.

CYRX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

38%

Avg EPS Surprise

+98.90%

Avg Stock Reaction

+1.25%

Last Quarter Recap

In Q1-2026, Cryoport reported an EPS of $-0.25, missing estimates and reflecting ongoing challenges in profitability. The stock dropped 1.35% the following day, indicating market disappointment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Cryoport to report a loss, but revenue is anticipated to show modest growth. The market is closely watching for any signs of improvement in operational efficiency.

Bull Case

If Cryoport can exceed revenue expectations and show a smaller loss than anticipated, it could signal a turnaround in performance, boosting investor confidence.

Bear Case

Conversely, if the company fails to meet revenue targets or reports a larger loss, it could raise concerns about its long-term viability and lead to a significant stock decline.

Key Metrics to Watch

EPS

$-0.18

Earnings per share is a key indicator of profitability and will show how well the company is managing its costs.

Revenue

$48M

Revenue figures will indicate the company's sales performance and growth trajectory in a competitive market.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS come in better than the expected $-0.18?

A smaller loss could indicate improved cost management and operational efficiency, which is critical for investor confidence.

What is the outlook for revenue growth compared to the $48M consensus?

Revenue growth is essential for demonstrating the company's ability to capture market share and sustain its operations.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Cryoport's potential for revenue growth due to recent investments in expanding its logistics capabilities.

Supporting Evidence

The options market is pricing a 25.97% move, indicating expectations of significant volatility.

Past earnings surprises show that the company has occasionally exceeded expectations despite a challenging environment.

Key Risk

If revenue comes in above $49M, it could challenge the current bearish sentiment and shift investor outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's results are pivotal in determining whether Cryoport can stabilize its financials and regain investor trust.

Bull Confirmed If

Revenue exceeding $48M with EPS better than $-0.18 would confirm a positive outlook.

Bear Confirmed If

Revenue falling below $47M or a larger EPS loss than $-0.20 would confirm concerns about the company's performance.

Pre-Earnings Positioning

Options Market

Implied Move

±25.97%

Historical Avg

±3.1%

Pricing rich

The options market is pricing in a significant move, suggesting that investors expect volatility around the earnings report.

Options are pricing ±26.0% while CYRX has averaged ±3.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.7%

30d HV

69.4%

Calls (307K)P/C Ratio: 0.00Puts (1K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cryoport beats expectations, history suggests a potential stock increase of around 1.99% on the first day, confirming a positive turnaround narrative.

In-Line / Cautious

If results are in line with expectations, the stock may see muted reactions as investors await further clarity on future growth.

Miss

If the company misses estimates, history suggests a potential decline of about 2.78%, reinforcing negative sentiment.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Details on cost management strategies and their impact on EPS.
3Insights into market demand for temperature-controlled logistics services.
4Management's commentary on competitive positioning in the life sciences sector.
5Future guidance on revenue expectations for the next quarter.